Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
1986 1
1987 2
1988 2
1989 1
1991 2
1992 2
1994 2
1996 1
1999 1
2000 3
2001 6
2002 6
2003 6
2004 9
2005 3
2006 9
2007 7
2008 5
2009 3
2010 4
2011 9
2012 7
2013 4
2014 8
2015 8
2016 3
2017 8
2018 9
2019 11
2020 16
2021 12
2022 9
2023 7
2024 11
2025 14
2026 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

184 results

Results by year

Filters applied: . Clear all
Page 1
Systematic review and meta-analysis: efficacy of peppermint oil in irritable bowel syndrome.
Ingrosso MR, Ianiro G, Nee J, Lembo AJ, Moayyedi P, Black CJ, Ford AC. Ingrosso MR, et al. Aliment Pharmacol Ther. 2022 Sep;56(6):932-941. doi: 10.1111/apt.17179. Epub 2022 Aug 9. Aliment Pharmacol Ther. 2022. PMID: 35942669 Free article.
Adverse event rates were significantly higher with peppermint oil (RR of any adverse event = 1.57; 95% CI 1.04-2.37). CONCLUSIONS: Peppermint oil was superior to placebo for the treatment of IBS, but adverse events were more frequent, and quality of evidence was ver …
Adverse event rates were significantly higher with peppermint oil (RR of any adverse event = 1.57; 95% CI 1.04-2.37). CONCLUSIONS: …
Ethnomedicinal, phytochemical and pharmacological updates on Peppermint (Mentha piperita L.)-A review.
Mahendran G, Rahman LU. Mahendran G, et al. Phytother Res. 2020 Sep;34(9):2088-2139. doi: 10.1002/ptr.6664. Epub 2020 Mar 16. Phytother Res. 2020. PMID: 32173933 Review.
Peppermint (Mentha piperita L) is a perennial, glabrous and strongly scented herb belongs to the family Lamiaceae. ...In addition to traditional food flavouring uses, M. piperita is well recognized for their traditional use to treat fever, cold, …
Peppermint (Mentha piperita L) is a perennial, glabrous and strongly scented herb belongs to the family Lamiaceae. .. …
Efficacy and Safety of Peppermint Oil in a Randomized, Double-Blind Trial of Patients With Irritable Bowel Syndrome.
Weerts ZZRM, Masclee AAM, Witteman BJM, Clemens CHM, Winkens B, Brouwers JRBJ, Frijlink HW, Muris JWM, De Wit NJ, Essers BAB, Tack J, Snijkers JTW, Bours AMH, de Ruiter-van der Ploeg AS, Jonkers DMAE, Keszthelyi D. Weerts ZZRM, et al. Gastroenterology. 2020 Jan;158(1):123-136. doi: 10.1053/j.gastro.2019.08.026. Epub 2019 Aug 27. Gastroenterology. 2020. PMID: 31470006 Clinical Trial.
We studied the efficacy and safety of small-intestinal-release peppermint oil in patients with IBS and explored the effects of targeted ileocolonic-release peppermint oil. ...RESULTS: Abdominal pain response did not differ significantly between the peppermint …
We studied the efficacy and safety of small-intestinal-release peppermint oil in patients with IBS and explored the effects of target …
Peppermint oil.
Kligler B, Chaudhary S. Kligler B, et al. Am Fam Physician. 2007 Apr 1;75(7):1027-30. Am Fam Physician. 2007. PMID: 17427617 Free article. Review.
Peppermint leaf and peppermint oil have a long history of use for digestive disorders. Recent evidence suggests that enteric-coated peppermint oil may be effective in relieving some of the symptoms of irritable bowel syndrome. ...Topical application of …
Peppermint leaf and peppermint oil have a long history of use for digestive disorders. Recent evidence suggests that en …
Review article: the physiological effects and safety of peppermint oil and its efficacy in irritable bowel syndrome and other functional disorders.
Chumpitazi BP, Kearns GL, Shulman RJ. Chumpitazi BP, et al. Aliment Pharmacol Ther. 2018 Mar;47(6):738-752. doi: 10.1111/apt.14519. Epub 2018 Jan 26. Aliment Pharmacol Ther. 2018. PMID: 29372567 Free PMC article. Review.
BACKGROUND: Peppermint oil has been used for centuries as a treatment for gastrointestinal ailments. ...Peppermint oil has been found to affect oesophageal, gastric, small bowel, gall-bladder, and colonic physiology. ...
BACKGROUND: Peppermint oil has been used for centuries as a treatment for gastrointestinal ailments. ...Peppermint oil has bee …
Herbal formula improves upper and lower gastrointestinal symptoms and gut health in Australian adults with digestive disorders.
Ried K, Travica N, Dorairaj R, Sali A. Ried K, et al. Nutr Res. 2020 Apr;76:37-51. doi: 10.1016/j.nutres.2020.02.008. Epub 2020 Feb 8. Nutr Res. 2020. PMID: 32151878 Free article. Clinical Trial.
The Nutrition Care (NC) Gut Relief Formula contains a combination of herbs and nutrients including curcumin, Aloe vera, slippery elm, guar gum, pectin, peppermint oil, and glutamine shown to benefit the GI system. The 16-week pre-post study tested the hypothesis tha …
The Nutrition Care (NC) Gut Relief Formula contains a combination of herbs and nutrients including curcumin, Aloe vera, slippery elm, guar g …
Gastrointestinal Pharmacology.
Saps M, Miranda A. Saps M, et al. Handb Exp Pharmacol. 2017;239:147-176. doi: 10.1007/164_2016_119. Handb Exp Pharmacol. 2017. PMID: 28236087 Review.
Thus, the decision on the most appropriate pharmacological treatment is frequently based on adult studies or empirical data. In children, peppermint oil, trimebutine, and drotaverine have shown significant benefit compared with placebo, each of them in a single randomized …
Thus, the decision on the most appropriate pharmacological treatment is frequently based on adult studies or empirical data. In children, …
European Consensus on Functional Bloating and Abdominal Distension-An ESNM/UEG Recommendations for Clinical Management.
Melchior C, Hammer H, Bor S, Barba E, Horvat IB, Celebi A, Drug V, Dumitrascu D, Kalkan IH, Hauser G, Lionis C, Livovsky D, Mari A, Mulak A, Surdea-Blaga T, Tack J, Vanuytsel T, Savarino EV, Zarate-Lopez N, Hammer J, Dickman R. Melchior C, et al. United European Gastroenterol J. 2025 Nov;13(9):1613-1651. doi: 10.1002/ueg2.70098. Epub 2025 Aug 22. United European Gastroenterol J. 2025. PMID: 40844856 Free PMC article. Review.
Treatment may include dietary modifications (e.g. lactose-limiting diet and low FODMAP diet), probiotics, antispasmodics (e.g., otilonium bromide, peppermint oil), rifaximin, secretagogues (e.g., linaclotide), neuromodulators (e.g., serotonin-norepinephrine reuptake inhibi …
Treatment may include dietary modifications (e.g. lactose-limiting diet and low FODMAP diet), probiotics, antispasmodics (e.g., otilonium br …
Esophageal and Oropharyngeal Dysphagia: Clinical Recommendations From the United European Gastroenterology and European Society for Neurogastroenterology and Motility.
Mari A, Calabrese F, Pasta A, Lorenzon G, Weusten B, Keller J, Visaggi P, Roman S, Marabotto E, Dickman R, Serra J, De Bortoli N, Iovino P, Pohl D, Dumitrascu D, Ribolsi M, Barber C, Bor S, Fox M, Sweiss R, Lorenzo-Zuniga V, Akyuz F, Ghisa M, Celebi A, Shibli F, Dziewas R, Kalkan IH, Tack J, Clavé P, Carrion S, Cheng I, Tomsen N, Ortega O, Rubio SM, Pizzorni N, Michou E, Regan J, Hamdy S, Rommel N, Scharitzer M, Ekberg O, Schindler A, Speyer R, Gillman A, Zerbib F, Savarino EV. Mari A, et al. United European Gastroenterol J. 2025 Jul;13(6):855-901. doi: 10.1002/ueg2.70062. Epub 2025 Jun 21. United European Gastroenterol J. 2025. PMID: 40543044 Free PMC article.
Regarding treatment, a weak recommendation was achieved for the use of PPIs, calcium-channel blockers, nitrates, phosphodiesterase type 5 inhibitors, antidepressants or peppermint oil for the treatment of hypercontractile esophagus. A strong recommendation exists for endos …
Regarding treatment, a weak recommendation was achieved for the use of PPIs, calcium-channel blockers, nitrates, phosphodiesterase type 5 in …
184 results